WAY-100,635

162760-96-5

71IH826FEG

Cyclohexanecarboxamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-

N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)cyclohexancarboxamid

N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)cyclohexanecarboxamide

N-{2-[4-(2-Méthoxyphényl)-1-pipérazinyl]éthyl}-N-(2-pyridinyl)cyclohexanecarboxamide

N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide

WAY 100,635

WAY-100,635

[Wiki]

WAY100,635

(N-{2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2- pyridinyl)-cyclohexanecarboxamide)

146714-97-8

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 1B

5-hydroxytryptamine receptor 1D

5-hydroxytryptamine receptor 1E

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 2B

5-hydroxytryptamine receptor 2C

5-hydroxytryptamine receptor 3A

5-hydroxytryptamine receptor 5A

5-hydroxytryptamine receptor 6

5-hydroxytryptamine receptor 7

5HT1A_HUMAN

5HT1A_RAT

5HT1B_HUMAN

5HT1D_HUMAN

5HT1E_HUMAN

5HT2A_HUMAN

5HT2A_RAT

5HT2B_HUMAN

5HT2C_RAT

5HT5A_HUMAN

5HT6R_HUMAN

5HT7R_HUMAN

634908-75-1

[³H]WAY100635

[³H]WAY100635

A0A1V4J3K6_PATFA

A0A1V4J4E5_PATFA

A0A1V4J7Y5_PATFA

A0A1V4JDN9_PATFA

A0A1V4JMG2_PATFA

A0A1V4KJJ8_PATFA

A0A1V4KRM0_PATFA

A0A1V4KYG9_PATFA

A0A218UVI3_9PASE

ACM2_HUMAN

ACM2_RAT

ACM5_HUMAN

ADA1A_HUMAN

ADA1A_RAT

ADA1B_HUMAN

ADA1D_HUMAN

ADA2A_HUMAN

ADA2B_HUMAN

ADA2C_HUMAN

ADA2C_RAT

ADRB1_RAT

ADRB2_RAT

Cyclohexanecarboxylic acid {2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-pyridin-2-yl-amide

D(1A) dopamine receptor

D(1B) dopamine receptor

D(2) dopamine receptor

D(3) dopamine receptor

D(4) dopamine receptor

DRD1_HUMAN

DRD1_RAT

DRD2_HUMAN

DRD2_RAT

DRD3_HUMAN

DRD3_RAT

DRD4_HUMAN

DRD5_HUMAN

GALA_RAT

Galanin peptides

GBRA1_RAT

Glutamate receptor 3

Glutamate receptor ionotropic, NMDA 1

GRIA3_RAT

Histamine H1 receptor

Histamine H2 receptor

Histamine H3 receptor

Histamine H4 receptor

HRH1_HUMAN

HRH1_RAT

HRH2_CAVPO

HRH2_HUMAN

HRH3_CAVPO

HRH4_HUMAN

Lopac0_001229

MFCD00916243

MFCD24386350

Muscarinic acetylcholine receptor M2

Muscarinic acetylcholine receptor M5

N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide

N-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-N-(pyridin-2-yl)cyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide

N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide

N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-yl-cyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide

N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide-Tritiated

Nicotinic acetylcholine receptor

NMDZ1_RAT

OPRD_HUMAN

OPRK_HUMAN

OPRM_HUMAN

PDSP1_001716

PDSP2_001699

Q62594_RATLE

trans-Cyclohexanecarboxylic acid {2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-pyridin-2-yl-amide

WAY 100635; WAY100635

α-1A adrenergic receptor

α-1B adrenergic receptor

α-1D adrenergic receptor

α-2A adrenergic receptor

α-2B adrenergic receptor

α-2C adrenergic receptor

β-1 adrenergic receptor

β-2 adrenergic receptor

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor